Study of GA for hard-to-treat nerve pain
Part of Brain & nervous system, Pain clinical trials.
This early-phase trial tests a new treatment called GA for people with hard-to-treat neuropathic pain that hasn't improved with standard therapies. The goal is to see if it is safe and tolerable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old and have a diagnosis of neuropathic pain (like diabetic nerve pain, trigeminal neuralgia, or post-stroke pain).
- You have tried at least two standard pain medications and other treatments for 3 months or more, but they did not help enough.
- Your average pain over the past week is at least 4 out of 10 on a standard pain scale.
- You have been on the same pain medications for at least 30 days and agree not to change them during the study.
- You are willing to use effective birth control (not oral contraceptives) and not plan to have children during the study.
- You do not have serious health issues like unstable heart disease, recent heart attack, severe liver or kidney problems, bleeding disorders, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a brain treatment guided by MRI to treat chronic nerve (neuropathic) pain that hasn’t improved with many prior treatments. It may help reduce pain intensity when standard pain medicines and procedures have not worked.
This trial tests a new medicine called HRS-2129 for people with long-term nerve pain caused by diabetes. It aims to see if the drug can safely reduce pain.
This trial tests a new medicine called crisugabalin to see if it safely reduces shingles pain. It may help if you have moderate to severe pain from a shingles rash that started less than 3 months ago.
This trial tests whether stimulating two brain networks with implanted electrodes can relieve chronic nerve pain that hasn't responded to other treatments. It is for people with severe pain lasting more than six months.
This trial tests a new type of spinal cord stimulation for people with long-term nerve pain that hasn't improved with other treatments. The goal is to see if this special stimulation pattern can reduce pain better than standard care.
This study tests new treatments for chronic pain that lasts at least 3 months. Participants must stop their regular pain medicines and use only a rescue painkiller if needed. The goal is to find better ways to manage long-term pain.
Hear when a new Pain, Intractable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.